XML 45 R35.htm IDEA: XBRL DOCUMENT v3.22.4
SHAREHOLDERS' EQUITY (Narrative) (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 22, 2021
USD ($)
$ / shares
shares
Jan. 31, 2016
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Sep. 30, 2022
shares
SHAREHOLDERS' EQUITY          
Options granted     20,000 120,000 1,347,500
Weighted average fair value of options granted | $ / shares     $ 3.11 $ 6.79  
Employee Share Purchase Plan [Member]          
SHAREHOLDERS' EQUITY          
Shares issued     19,298 2,444  
Offering term     6 months    
Maximum eligibility to common shares amount | $     $ 25,000    
Stock Options [Member]          
SHAREHOLDERS' EQUITY          
Option expiration period     10 years    
Minimum | Employee Share Purchase Plan [Member]          
SHAREHOLDERS' EQUITY          
Price percentage of common share granted     85.00%    
Maximum | Employee Share Purchase Plan [Member]          
SHAREHOLDERS' EQUITY          
Common shares reserved for issuance     217,300 249,974  
Employee contribution percentage     15.00%    
Maximum | Stock Options and RSU Plan [Member]          
SHAREHOLDERS' EQUITY          
Common shares reserved for issuance     8,410,907    
February 2021 Financing [Member]          
SHAREHOLDERS' EQUITY          
Aggregate gross proceeds | $ $ 149,999,985        
Shares issued 5,555,555        
Offering price per share | $ / shares $ 27.00        
Underwriter option to purchase additional securities 724,637        
Term of underwriters option 30 days        
Cash commissions paid | $ $ 8,999,999        
Share issuance transaction costs | $ $ 229,451        
Private Placement [Member]          
SHAREHOLDERS' EQUITY          
Shares issued   227,273      
Offering price per share | $ / shares   $ 66.00      
Number of Units issued   227,273      
Units issued in private placement, conversion ratio   1      
Private Placement [Member] | 2 Year Warrants [Member]          
SHAREHOLDERS' EQUITY          
Term of warrant   2 years      
Units issued in private placement, conversion ratio   0.5      
Private Placement [Member] | 7 Year Warrants [Member]          
SHAREHOLDERS' EQUITY          
Term of warrant   7 years      
Units issued in private placement, conversion ratio   1      
Private Placement [Member] | Clarus Lifesciences III, L.P [Member]          
SHAREHOLDERS' EQUITY          
Number of shares acquired by shareholders   106,061      
Minimum number of shares required to be held for nomination rights   53,030